DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» David Goltzman
David Goltzman
Inhibits Parathyroid Hormone- Related Peptide Production and Prevents the Development of Malignancy-Associated Hypercalcemia in Vivo
Faculty of Medicine (Graduate) Programs, Courses and University Regulations 2013-2014
Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer1
Bisphosphonates for Treatment of Osteoporosis Expected Benefts, Potential Harms, and Drug Holidays
Vital Signs Vital Signs
Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D
Targeted Ablation of the 25-Hydroxyvitamin D 1 -Hydroxylase
Jewish General Hospital April 1, 2009 - March 31, 2010
The Effects of GSPT1 Degradation on Serum Calcium, Parathyroid Hormone, and Fibroblast Growth Factor 23 Concentrations in Human Cereblon Knock-In Mice
2004-2005 Mcgill University Department of Medicine Annual
Honours, Awards and Prizes January 1, 2017 to December 31, 2017
Jewish General Hospital Awards
Dysregulation of Parathyroid Hormone-Like Peptide Expression and Secretion in a Keratinocyte Model of Tumor Progression1
2009 Bone Health Research Consensus Conference (BHRCC)
CURRICULUM VITAE: Dr
Front Matter
Koutsilieris Is an Endocrinologist, Holding the Position “Professor Of
Temporal Trends and Determinants of Longitudinal Change in 25-Hydroxyvitamin D and Parathyroid Hormone Levels
Top View
Comparison of Active Vitamin D Compounds and a Calcimimetic in Mineral Homeostasis
Issue Dec 2000
Induction of Parathyroid Hormone
The Osteoporosis Primer Edited by Janet E
Bone & Mineral Metabolism Fellowship
Name Dr J. Brent RICHARDS, MD, Msc Associate Professor
Parathyroid Hormone Is Essential for Normal Fetal Bone Formation